Quantcast

Latest Lausanne Stories

2009-10-05 01:30:00

LAUSANNE, Switzerland, October 5 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and the Japanese Cancer Association (JCA) presented 'The JCA-Mauvernay Award' to Dr Toshikazu Ushijima from the National Cancer Center Research Institute in Tokyo, for his outstanding and innovative research in basic science in the "epigenetic field for cancerization".

2009-09-07 01:30:00

PARIS and LAUSANNE, Switzerland, September 7 /PRNewswire/ -- Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of...

2009-09-03 10:00:00

LAUSANNE, Switzerland, September 3 /PRNewswire/ -- Debiopharm Group, SA (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today presented the 'Debiopharm Life Sciences Award' to Dr Lluis Quintana-Murci from the Institut Pasteur in France, for his outstanding innovative research in the emerging field of evolutionary genetics of infection.

2009-07-21 04:18:00

LAUSANNE, Switzerland, July 21 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced that the Swiss agency for therapeutic products, Swissmedic, has issued a marketing authorisation for Moapar(R) 11.25mg, the first 3-month injectable formulation, prescribed for a reversible reduction of serum testosterone to the level of castration in adult...

2009-06-23 04:48:00

LAUSANNE, Switzerland, June 23 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced that Salvacyl(R) (also known under the trade names Moapar(R) and Salvapar(R)), was launched in Germany in May 2009, by Dr R.

721bf686865327d446596d0a758d2d111
2009-06-17 10:23:06

Representatives from the four cities vying to become the host site for the 2016 Olympics gave presentations Wednesday to the International Olympic Committee. Chicago, Madrid, Rio de Janeiro and Tokyo are the finalists for the 2016 Games.

2009-05-05 13:09:00

First Shareholder Meeting Since Split Draws Global Protest NEW YORK, May 5 /PRNewswire-USNewswire/ -- With global tobacco deaths climbing above 5.4 million a year, Philip Morris International (PMI) is heralding a 12.7 percent net revenue growth in 2008.

2009-04-30 04:05:00

LAUSANNE, Switzerland, April 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions, particularly in the field of oncology, announced that on April 7, 2009 the last patient was randomised to take part in a phase IIb clinical study with Debio 025, a selective cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C (HCV) effect.

2009-04-23 18:12:00

World Malaria Day Events Held in Nairobi, London, Washington LAUSANNE, Switzerland, April 23 /PRNewswire/ -- To honor the theme for World Malaria Day on 4/25, 'Counting Malaria Out,' Vestergaard Frandsen is stepping up production of its best selling bed net, called PermaNet(R), and introducing a new version that is effective against insecticide resistant mosquitoes.

2009-02-03 09:08:55

Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.


Word of the Day
ecotone
  • A transitional zone between two communities containing the characteristic species of each.
The word 'ecotone' comes 'eco-' plus a Greek root meaning 'tension'.